Canada Approves Moderna Vaccine

Health Canada has approved Moderna’s COVID-19 vaccine for use locally after reviewing clinical trial reports and ordered at least 168,000 doses.

Health Canada has approved Moderna’s COVID-19 vaccine for use locally after reviewing clinical trial reports and ordered at least 168,000 doses.

The first doses are expected to arrive by Christmas while the rest are scheduled until the end of the year.

Moderna’s is the second COVID-19 vaccine to be approved after the Pfizer-BioNTech variant last week. 

Moderna has promised Canada 40 million doses by the end of 2021.

“The ongoing COVID-19 pandemic has a significant impact on public health. The availability of safe and effective vaccines will reduce the spread and severity of COVID-19 disease and reduce its social and economic consequences,” said Health Canada.

The Pfizer-BioNTech vaccine is already being administered across Canada to people in high-priority groups, including health-care workers as well as long-term care workers and residents.

Health Canada explained that the Moderna vaccine does not have any safety concerns warned against possible allergic reactions and possible side effects.

The Moderna vaccine needs two doses to achieve maximum immunity and delivered two months apart just like the Pfizer-BioNTech variant.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.